Trial of Olaparib in Patients With Metastatic Urothelial Cancer Harboring DNA Damage Response Gene Alterations
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to AstraZeneca
Related studies linked through entity extraction aliases.
Fulvestrant Versus Fulvestrant Plus Palbociclib in Operable Breast Cancer Responding to Fulvestrant
- Status
- COMPLETED
- Phase
- PHASE3
Ablative STEreotactic RadiOtherapy wIth Durvalumab (MEDI4736)
- Status
- COMPLETED
- Phase
- PHASE2
ADHERE-S (NIS Brilique)
- Status
- COMPLETED
- Phase
- N/A
Low Maintenance Dose Ticagrelor Versus Clopidogrel in Diabetes Patients Undergoing PCI
- Status
- COMPLETED
- Phase
- PHASE4
A Study to Evaluate the Safety, Tolerability and Absorption to the Blood After Administration of Single and Multiple Doses of AZD8154 in Healthy Participants.
- Status
- COMPLETED
- Phase
- PHASE1
Multiple-ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD9977 in Healthy Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Olaparib Maintenance in Patients With MCRPC After Docetaxel Treatment Reaching Partial or Stable Response (IMANOL)
- Status
- COMPLETED
- Phase
- PHASE2
An Epidemiologic Study on PD-L1 Expression Combined With Clinical Observation in the Chinese MIUBC Patients.
- Status
- COMPLETED
- Phase
- N/A
Osimertinib in Treating Participants With Stage I-IIIA EGFR-mutant Non-small Cell Lung Cancer Before Surgery
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
SARC031: MEK Inhibitor Selumetinib (AZD6244) in Combination With the mTOR Inhibitor Sirolimus for Patients With Malignant Peripheral Nerve Sheath Tumors
- Status
- COMPLETED
- Phase
- PHASE2
BrUOG 337: Olaparib Prior to Radical Prostatectomy For Advanced Prostate Cancer Defects in DNA Repair Genes
- Status
- TERMINATED
- Phase
- PHASE2
Evaluating Immune Therapy, Durvalumab (MEDI4736) With Tremelimumab for Metastatic, Non-transitional Cell Carcinoma of the Urinary Tract
- Status
- COMPLETED
- Phase
- PHASE2
Durvalumab and Eribulin in Her2-negative Metastatic Breast Cancer and Recurrent Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study of Durvalumab (MEDI4736) (Anti-PD-L1) and Trametinib (MEKi) in MSS Metastatic Colon Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Cross-sectional Study of COPD and Symptom Variability in MEA Countries
- Status
- COMPLETED
- Phase
- N/A
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
- Status
- RECRUITING
- Phase
- PHASE1
AZD9150 Plus Durvalumab Alone or in Combination With Chemotherapy in Patients With Advanced, Solid Tumours and in Patients With Non-Small-Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Assess the Bioavailability of Different Formulations of AZD5718 and the Food Effect on the Selected Formulation of AZD5718 in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
The Potential of Dapagliflozin Plus Exenatide in Obese Insulin-resistant Patients
- Status
- TERMINATED
- Phase
- PHASE3